Hotta K - Search Results

1

Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials.

Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Hotta K, et al. Ann Oncol. 2004 Dec;15(12):1782-9. doi: 10.1093/annonc/mdh476. Ann Oncol. 2004. PMID: 15550583 Free article.

2

Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience.

Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Harita S, Gemba K, Yonei T, Bessho A, Tanimoto M. Hotta K, et al. Ann Oncol. 2005 Nov;16(11):1817-23. doi: 10.1093/annonc/mdi369. Epub 2005 Sep 12. Ann Oncol. 2005. PMID: 16157622 Free article.

3

Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: possible influence of type of platinum on survival data.

Hotta K, Kiura K. Hotta K, et al. Ann Oncol. 2006 Nov;17(11):1724. doi: 10.1093/annonc/mdl130. Epub 2006 Jun 21. Ann Oncol. 2006. PMID: 16790521 Free article. No abstract available.

4

Association between incremental gains in the objective response rate and survival improvement in phase III trials of first-line chemotherapy for extensive disease small-cell lung cancer.

Hotta K, Kiura K, Fujiwara Y, Takigawa N, Oze I, Ochi N, Tabata M, Tanimoto M. Hotta K, et al. Ann Oncol. 2009 May;20(5):829-34. doi: 10.1093/annonc/mdp020. Epub 2009 Feb 16. Ann Oncol. 2009. PMID: 19221150 Free article.

5

Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment.

Fujiwara Y, Hotta K, Di Maio M, Kiura K, Takigawa N, Tabata M, Tanimoto M. Fujiwara Y, et al. Among authors: hotta k. Ann Oncol. 2011 Feb;22(2):376-82. doi: 10.1093/annonc/mdq360. Epub 2010 Aug 10. Ann Oncol. 2011. PMID: 20699278 Free article. Clinical Trial.

6

A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403.

Oda N, Hotta K, Ninomiya K, Minami D, Ichihara E, Murakami T, Yokoyama T, Ichikawa H, Chikamori K, Takigawa N, Ochi N, Harita S, Maeda Y, Kiura K. Oda N, et al. Among authors: hotta k. Cancer Chemother Pharmacol. 2018 Dec;82(6):1031-1038. doi: 10.1007/s00280-018-3694-5. Epub 2018 Oct 1. Cancer Chemother Pharmacol. 2018. PMID: 30276451 Clinical Trial.

7

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.

Hotta K, Saeki S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Gemba K, Shiojiri M, Kato Y, Ninomiya T, Kubo T, Kishimoto J, Shioyama Y, Katsui K, Sasaki J, Kiura K, Sugio K. Hotta K, et al. ESMO Open. 2021 Aug;6(4):100191. doi: 10.1016/j.esmoop.2021.100191. Epub 2021 Jun 18. ESMO Open. 2021. PMID: 34153652 Free PMC article. Clinical Trial.

8

Distant failure after treatment of postoperative locoregional recurrence of non-small cell lung cancer.

Hotta K, Sekine I, Suzuki K, Kondo H, Asamura H, Sumi M, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Saijo N, Tsuchiya R. Hotta K, et al. Thorac Cardiovasc Surg. 2003 Oct;51(5):283-7. doi: 10.1055/s-2003-43089. Thorac Cardiovasc Surg. 2003. PMID: 14571346

9

Corrigendum to 'Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study': [ESMO Open Volume 6, Issue 4, August 2021, 100191].

Hotta K, Saeki S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Gemba K, Shiojiri M, Kato Y, Ninomiya T, Kubo T, Kishimoto J, Shioyama Y, Katsui K, Sasaki J, Kiura K, Sugio K. Hotta K, et al. ESMO Open. 2022 Aug;7(4):100532. doi: 10.1016/j.esmoop.2022.100532. Epub 2022 Jul 6. ESMO Open. 2022. PMID: 35802950 Free PMC article. No abstract available.

10

A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.

Hotta K, Sekine I, Tamura T, Sawada M, Watanabe H, Kusaba H, Akiyama Y, Inoue A, Shimoyama T, Nokihara H, Ueda Y, Yamamoto N, Kunitoh H, Ohe Y, Kodama T, Saijo N. Hotta K, et al. Jpn J Clin Oncol. 2001 Dec;31(12):596-600. doi: 10.1093/jjco/hye129. Jpn J Clin Oncol. 2001. PMID: 11902490 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,542 results

Search Page

Filters